Skip to main content
Morepen Laboratories Ltd. logo

Morepen Laboratories Ltd. — Investor Relations & Filings

Ticker · MOREPENLAB ISIN · INE083A01026 LEI · 335800OJZDFHFQJ4HP35 BSE.NS Manufacturing
Open in API
Filings indexed 1,660 across all filing types
Latest filing 2021-09-01 Board/Management Inform…
Country IN India
Listing BSE.NS MOREPENLAB

About Morepen Laboratories Ltd.

https://www.morepen.com

Morepen Laboratories Ltd. is a research-led company specializing in the development, manufacturing, and marketing of Active Pharmaceutical Ingredients (APIs), home diagnostic devices, and finished formulations. The company maintains a significant global presence, exporting high-quality APIs such as Loratadine, Montelukast, Atorvastatin, and Fexofenadine to numerous international markets. Its diagnostic division, branded as Dr. Morepen, is a prominent player in the home healthcare segment, offering a wide range of products including digital glucometers, blood pressure monitors, and nebulizers. Morepen operates manufacturing facilities compliant with international regulatory standards, including USFDA approvals. The company focuses on leveraging its R&D capabilities to deliver healthcare solutions and maintains a diverse portfolio across various therapeutic areas including cardiovascular, anti-diabetic, and anti-asthmatic treatments.

Recent filings

Filing Released Lang Actions
Pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we wish to inform that, the Board of Directors of the company in their meeting ....
Board/Management Information Classification · 100% confidence The document is an official communication addressed to stock exchanges (NSE and BSE) regarding the outcome of a Board Meeting held on September 1, 2021. It discloses a significant corporate action: the transfer of the Medical Devices Business to a wholly owned subsidiary on a slump sale basis. The document references compliance with Regulation 30 of the SEBI Listing Regulations and includes detailed disclosure information as per SEBI circular CIR/CFD/CMD/4/2015. The content focuses on the announcement of a corporate transaction approved by the Board, including business rationale, financial details, and expected timelines. There are no financial statements or detailed financial performance data presented, nor is this a transcript, report, or presentation. The document is a formal announcement of a Board decision and related corporate action, fitting the category of Board/Management Information (MANG).
2021-09-01 English
Loss of Share Certificates
Regulatory Filings Classification · 95% confidence The document is a letter addressed to stock exchanges (NSE and BSE) regarding the issue of duplicate share certificates. It references Regulation 39(3) of the SEBI Listing Obligations and Disclosure Requirements, which pertains to share certificate management. The content is about informing the exchanges about the issuance of duplicate share certificates to shareholders, listing folio numbers, old and new certificate numbers, and shareholder names. There is no financial data, no discussion of financial results, no management commentary, no voting results, no legal proceedings, no capital changes, or other report types. The document is an official regulatory communication about share certificate issuance, which fits best under Regulatory Filings (RNS) as it is a compliance-related announcement that does not fit other specific categories. The document length is 4179 characters, which is relatively short and consistent with a regulatory filing rather than a full report or announcement of a report publication.
2021-08-31 English
Pursuant to the Regulation 39(3) of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, as amended, please find attached herewith letter dated 31st August, ....
Regulatory Filings Classification · 95% confidence The document is a letter addressed to stock exchanges (NSE and BSE) regarding the issue of duplicate share certificates. It references Regulation 39(3) of the SEBI Listing Obligations and Disclosure Requirements, which pertains to share certificate management. The content is about informing the exchanges about the issuance of duplicate share certificates to shareholders. There is no financial data, no report attached or referenced, no management discussion, no earnings information, or any other financial or governance report. The document is an official regulatory communication about share certificate issuance, which fits best under Regulatory Filings (RNS) as it is a compliance-related announcement that does not fit other specific categories like share issue or capital change (SHA) because it is about duplicate certificates, not new shares or capital changes. The document length is 4179 characters, which is relatively short and consistent with a regulatory filing letter. Therefore, the appropriate classification is Regulatory Filings (RNS).
2021-08-31 English
Loss of Share Certificates
Regulatory Filings Classification · 95% confidence The document is a letter addressed to stock exchanges regarding the loss of share certificates, referencing a regulatory requirement (Regulation 39(3) of SEBI Listing Obligations). It is an official notification about a specific event related to share certificates, not a financial report, earnings release, or management discussion. The document is short (1470 characters) and serves as a regulatory announcement. It does not contain financial data or detailed report content. Therefore, it fits best under Regulatory Filings (RNS), which is the fallback category for miscellaneous regulatory announcements that do not fit other specific categories.
2021-08-27 English
Pursuant to the Regulation 39(3) of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, as amended, please find attached herewith letters dated 25th August, 2021, ....
Regulatory Filings Classification · 100% confidence The document is a formal communication addressed to stock exchanges (NSE and BSE) regarding the loss of share certificates by shareholders and the request for issuance of duplicate share certificates. It references Regulation 39(3) of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, which pertains to reporting such events. The content consists of letters from the Registrar and Share Transfer Agent informing the exchanges about these losses. There is no financial data, no discussion of financial results, no management commentary, no voting results, no legal proceedings, or any other report type content. The document is essentially a regulatory notification about share certificate loss incidents. It is not an announcement of a report publication, nor a financial or governance report. This fits best under Regulatory Filings (RNS), which is the fallback category for miscellaneous regulatory announcements that do not fit other specific categories.
2021-08-27 English
Loss of Share Certificates
Regulatory Filings Classification · 95% confidence The document is a letter addressed to stock exchanges (NSE and BSE) regarding the loss of a share certificate and the request for issuance of duplicate share certificates. It references Regulation 39(3) of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. The content is a notification about a shareholder's lost share certificate and does not contain financial data, management discussion, or any report. It is not an annual report, earnings release, or any financial report. It is also not a voting result, board change, or capital update. The document is a regulatory notification related to share certificate loss, which fits best under Regulatory Filings (RNS) as it is a compliance-related announcement without substantive financial or strategic content.
2021-08-18 English

Browse filings by year

16 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.